THE SYSTEMIC ADMINISTRATION OF INTRAVENOUS MELPHALAN

被引:105
作者
SAROSY, G
LEYLANDJONES, B
SOOCHAN, P
CHESON, BD
机构
关键词
D O I
10.1200/JCO.1988.6.11.1768
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1768 / 1782
页数:15
相关论文
共 110 条
[1]   EFFECT OF RENAL DYSFUNCTION IN DOGS ON THE DISPOSITION AND MARROW TOXICITY OF MELPHALAN [J].
ALBERTS, DS ;
CHEN, HSG ;
BENZ, D ;
MASON, NL .
BRITISH JOURNAL OF CANCER, 1981, 43 (03) :330-334
[2]  
ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P73
[3]  
ALBERTS DS, 1979, CLIN PHARMACOL THER, V26, P737
[4]  
ANDERSON CC, 1986, CANCER CHEMOTH PHARM, V16, P170
[5]  
ANTMAN K, 1987, CANCER TREAT REP, V71, P119
[6]  
ARIEL IM, 1962, SURGERY, V51, P583
[7]   HIGH-DOSE THERAPY AND AUTOLOGOUS MARROW TRANSPLANTATION AS SALVAGE TREATMENT FOR PATIENTS WITH DIFFUSE LARGE CELL LYMPHOMA [J].
ARMITAGE, JO ;
JAGANNATH, S ;
SPITZER, G ;
BIERMAN, P ;
KESSINGER, A ;
KUMAR, P ;
CABANILLAS, F ;
ZANDER, A ;
VELLEKOOP, L ;
DICKE, KA .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (07) :871-877
[8]   TREATMENT OF ADVANCED NEURO-BLASTOMA WITH SUPRALETHAL CHEMOTHERAPY, RADIATION, AND ALLOGENEIC OR AUTOLOGOUS MARROW RECONSTITUTION [J].
AUGUST, CS ;
SEROTA, FT ;
KOCH, PA ;
BURKEY, E ;
SCHLESINGER, H ;
ELKINS, WL ;
EVANS, AE ;
DANGIO, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :609-616
[9]  
BARLOGIE B, IN PRESS BLOOD
[10]  
BEGLEITER A, 1979, CANCER RES, V39, P353